Friday, June 8, 2012

Concurrent Session - Bariatric Medicine

Co-Chairs: Drs. Maria Tiboni, Stephen Glazer

International Diabetes Federation Position Statement and Surgery: Does it change anything?

Bariatric surgery represents a potent treatment option for the obese patient with type 2 diabetes mellitus, resulting in improvement or remission of T2DM in the vast majority of patients. In light of the natural history of worsening of T2DM with time, and the difficulty in maintaining glycemic control particularly in severely insulin resistant patients, bariatric surgery should be considered as a potential treatment option for patients with BMI ≥35 in whom other treatment modalities have been unsuccessful. Though recent literature suggests that preoperative BMI may not be predictive of diabetes remission, further study is needed to examine whether bariatric surgery should be offered to patients with T2DM and a BMI between 30-35. The presence of T2DM should be taken into consideration in choosing the most appropriate type of bariatric surgery for the patient.

Learning Objectives

  • To review the key features and recommendations of the IDF Position Statement on the use of bariatric surgery in the treatment of obese patients with type 2 diabetes.
  • To discuss where bariatric surgery fits in the management paradigm of a type 2 diabetic with BMI ≥35.
  • To discuss whether bariatric surgery should be offered to patients with T2DM and a BMI between 30-35.

Speaker

Sue D. Pedersen, MD, FRCPC
Specialist in Endocrinology & Metabolism
LMC Endocrinology Centre
Calgary, AB, Canada

Dr. Sue Pedersen is a Specialist in Endocrinology and Metabolism, having completed her endocrinology training at the University of Calgary in 2005. Dr. Sue spent the year 2009 on a year-long research sabbatical at the Department of Human Nutrition at the University of Copenhagen, Denmark, where she had the privilege of doing research in the areas of obesity and gastric bypass surgery. Since returning to Canada, Dr. Sue has a busy endocrinology practice in Calgary, with a focus on type 2 diabetes and obesity. She maintains her research involvement in Denmark, and has several clinical research trials ongoing in Alberta as well. She also maintains a public information website about weight management and diabetes: www.drsue.ca.